Publications Database

Bhatti I. et al. (2013)

A retrospective study of amitriptyline in youth with autism spectrum disorders.

Journal of Autism and Developmental Disorders

43(5), pp. 1017-1027.

Read Abstract (New Window)

Birmaher B. , Quintana H. , Greenhill L. L. (1988)

Brief report: Methylphenidate treatment of hyperactive autistic children.

Journal of the American Academy of Child and Adolescent Psychiatry

27(2), pp. 248-251

Read Abstract (New Window)

Boon-Yasidhi V. et al. (2002)

Risperidone in the treatment of autistic Thai children under 4 years of age.

Journal of the Medical Association of Thailand

85 s. 784-789

Read Abstract (New Window)

Boris M. et al. (2007)

Effect of pioglitazone treatment on behavioral symptoms in autistic children.

Journal of Neuroinflammation

4(3),

Read Abstract (New Window) Read Full (New Window)

Boris M. , Goldblatt A. , Edelson S. M. (2006)

Improvement in children with autism treated with intravenous gamma globulin.

Journal of Nutritional and Environmental Medicine

15(4), 169-176

Read Abstract (New Window) Read Full (New Window)

Bradstreet J. J. et al. (2007)

Spironolactone might be a desirable immunologic and hormonal intervention in autism spectrum disorders.

Medical Hypotheses

68(5), pp. 979-987

Read Abstract (New Window) Read Full (New Window)

Brasić J. R. (1997)

Hyperkinesias in a prepubertal boy with autistic disorder treated with haloperidol and valproic acid.

Psychology Report

80(1), pp. 163-170

Read Abstract (New Window)

Brockett S. S. , Lawton-Shirley N. K. , Kimball J. G. (2014)

Berard auditory integration training: Behavior changes related to sensory modulation.

Autism Insights

Read Abstract (New Window) Read Full (New Window)

Campbell M. et al. (1990)

Naltrexone in autistic children: a double-blind and placebo-controlled study.

Psychopharmacology Bulletin

26(1), pp. 130-135

Read Abstract (New Window)

Campbell M. et al. (1993)

Naltrexone in autistic children: behavioral symptoms and attentional learning.

Journal of the American Academy of Child and Adolescent Psychiatry

32(6), pp. 1283-1291

Read Abstract (New Window)

Campbell M. , Cueva J. E. (1995)

Psychopharmacology in child and adolescent psychiatry: a review of the past seven years: Part 1

Journal of the American Academy of Child and Adolescent Psychiatry

34(9), pp. 1124-1132

Read Abstract (New Window)

Canitano R. , Scandurra V. (2008)

Risperidone in the treatment of behavioral disorders associated with autism in children and adolescents.

Neuropsychiatric Disease and Treatment

4(4), pp. 723-730

Read Abstract (New Window) Read Full (New Window)

Capone G. et al. (2008)

Risperidone use in children with Down syndrome, severe intellectual disability, and comorbid autistic spectrum disorders: A naturalistic study.

Journal of Developmental and Behavioral Pediatrics

29(2), pp. 106-116

Read Abstract (New Window)

Carminati G. G. , Deriaz N. , Bertschy G. (2006)

Low-dose venlafaxine in three adolescents and young adults with autistic disorder improves self-injurious behavior and attention deficit/hyperactivity disorders (ADHD)-like symptoms

Progress in Neuro-Psychopharmacology and Biological Psychiatry

30(2), pp. 312-315

Read Abstract (New Window)

Casanova M. F. et al. (2014)

Effects of weekly low-frequency rTMS on autonomic measures in children with autism spectrum disorder.

Frontiers in Human Neuroscience

Read Abstract (New Window) Read Full (New Window)

Charnsil C. (2011)

Efficacy of atomoxetine in children with severe autistic disorders and symptoms of ADHD: An open-label study.

Journal of Attention Disorders

15(8), pp. 684-689

Read Abstract (New Window)

Chavez B. , Chavez-Brown M. , Rey J. (2006)

Role of risperidone in children with autism spectrum disorder.

Annals of Pharmacotherapy

40(5), pp. 909-916

Read Abstract (New Window)

Cheng Y. et al. (2017)

Supplementation of omega 3 fatty acids may improve hyperactivity, lethargy, and stereotypy in children with autism spectrum disorders: a meta-analysis of randomized controlled trials.

Neuropsychiatric Disease and Treatment

13 pp. 2531–2543.

Read Abstract (New Window) Read Full (New Window)

Ching H. , Pringsheim T. (2012)

Aripiprazole for autism spectrum disorders (ASD).

Cochrane Database of Systematic Reviews

Read Abstract (New Window) Read Full (New Window)

Corson A. et al. (2004)

A retrospective analysis of quetiapine in the treatment of pervasive developmental disorders.

Journal of Clinical Psychiatry

65(1), pp. 1531-1536

Read Abstract (New Window)